Literature DB >> 9032364

Glycoprotein H of herpes simplex virus type 1 requires glycoprotein L for transport to the surfaces of insect cells.

D F Westra1, K L Glazenburg, M C Harmsen, A Tiran, A Jan Scheffer, G W Welling, T Hauw The, S Welling-Wester.   

Abstract

In mammalian cells, formation of heterooligomers consisting of the glycoproteins H and L (gH and gL) of herpes simplex virus type 1 is essential for the cell-to-cell spread of virions and for the penetration of virions into cells. We examined whether formation of gH1/gL1 heterooligomers and cell surface expression of the complex occurs in insect cells. Three recombinant baculoviruses, expressing gL1, gH1, and truncated gH1 (gH1t), which lacks the transmembrane region, were constructed. It was shown that recombinant gH1/gL1 and gH1t/gL1 heterooligomers were produced in insect cells. As in mammalian cells, gH1 and gH1t were not detected on the surfaces of insect cells in the absence of gL1. When coexpressed with gL1, recombinant gH1 was displayed on the surfaces of insect cells. Coexpression of gH1t and gL1 resulted in secretion of the gH1t/gL1 complex into the cell culture medium, indicating that gH1t is also transported to the surfaces of insect cells. Our results indicate that the process of folding and intracellular transport of gH1 and gL1 is comparable in insect cells and mammalian cells and that the baculovirus expression system can be used to examine the complex formation and the intracellular transport of gH1 and gL1. The availability of secreted gH1t/gL1 complex offers the opportunity to further investigate the immunological properties of this complex.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9032364      PMCID: PMC191337     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  41 in total

1.  Discrimination of viable and non-viable cells using propidium iodide in two color immunofluorescence.

Authors:  D T Sasaki; S E Dumas; E G Engleman
Journal:  Cytometry       Date:  1987-07

2.  DNA sequence of the herpes simplex virus type 1 gene encoding glycoprotein gH, and identification of homologues in the genomes of varicella-zoster virus and Epstein-Barr virus.

Authors:  D J McGeoch; A J Davison
Journal:  Nucleic Acids Res       Date:  1986-05-27       Impact factor: 16.971

3.  Excretion of non-infectious virus particles lacking glycoprotein H by a temperature-sensitive mutant of herpes simplex virus type 1: evidence that gH is essential for virion infectivity.

Authors:  P J Desai; P A Schaffer; A C Minson
Journal:  J Gen Virol       Date:  1988-06       Impact factor: 3.891

4.  Identification of the Epstein-Barr virus gp85 gene.

Authors:  T Heineman; M Gong; J Sample; E Kieff
Journal:  J Virol       Date:  1988-04       Impact factor: 5.103

5.  Monoclonal antibodies against herpes simplex viruses.

Authors:  A J Scheffer; D G Koedijk; T Abee; A D Osterhaus
Journal:  Dev Biol Stand       Date:  1984

6.  Characterisation and physical mapping of an HSV-1 glycoprotein of approximately 115 X 10(3) molecular weight.

Authors:  E A Buckmaster; U Gompels; A Minson
Journal:  Virology       Date:  1984-12       Impact factor: 3.616

7.  The properties and sequence of glycoprotein H of herpes simplex virus type 1.

Authors:  U Gompels; A Minson
Journal:  Virology       Date:  1986-09       Impact factor: 3.616

8.  Propidium iodide as a nuclear marker in immunofluorescence. II. Use with cellular identification and viability studies.

Authors:  C J Yeh; B L Hsi; W P Faulk
Journal:  J Immunol Methods       Date:  1981       Impact factor: 2.303

9.  Identification and expression of a human cytomegalovirus glycoprotein with homology to the Epstein-Barr virus BXLF2 product, varicella-zoster virus gpIII, and herpes simplex virus type 1 glycoprotein H.

Authors:  M P Cranage; G L Smith; S E Bell; H Hart; C Brown; A T Bankier; P Tomlinson; B G Barrell; T C Minson
Journal:  J Virol       Date:  1988-04       Impact factor: 5.103

10.  A novel herpes simplex virus glycoprotein, gL, forms a complex with glycoprotein H (gH) and affects normal folding and surface expression of gH.

Authors:  L Hutchinson; H Browne; V Wargent; N Davis-Poynter; S Primorac; K Goldsmith; A C Minson; D C Johnson
Journal:  J Virol       Date:  1992-04       Impact factor: 5.103

View more
  12 in total

1.  Pseudorabies virus glycoprotein L is necessary for virus infectivity but dispensable for virion localization of glycoprotein H.

Authors:  B G Klupp; W Fuchs; E Weiland; T C Mettenleiter
Journal:  J Virol       Date:  1997-10       Impact factor: 5.103

2.  Multiplex sequencing of seven ocular herpes simplex virus type-1 genomes: phylogeny, sequence variability, and SNP distribution.

Authors:  Aaron W Kolb; Marie Adams; Eric L Cabot; Mark Craven; Curtis R Brandt
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-11-25       Impact factor: 4.799

3.  Glycoprotein gL-independent infectivity of pseudorabies virus is mediated by a gD-gH fusion protein.

Authors:  B G Klupp; T C Mettenleiter
Journal:  J Virol       Date:  1999-04       Impact factor: 5.103

4.  Calcium phosphate nanoparticle adjuvant.

Authors:  Q He; A R Mitchell; S L Johnson; C Wagner-Bartak; T Morcol; S J Bell
Journal:  Clin Diagn Lab Immunol       Date:  2000-11

5.  The gH-gL complex of herpes simplex virus (HSV) stimulates neutralizing antibody and protects mice against HSV type 1 challenge.

Authors:  T Peng; M Ponce-de-Leon; H Jiang; G Dubin; J M Lubinski; R J Eisenberg; G H Cohen
Journal:  J Virol       Date:  1998-01       Impact factor: 5.103

6.  Structural and antigenic analysis of a truncated form of the herpes simplex virus glycoprotein gH-gL complex.

Authors:  T Peng; M Ponce de Leon; M J Novotny; H Jiang; J D Lambris; G Dubin; P G Spear; G H Cohen; R J Eisenberg
Journal:  J Virol       Date:  1998-07       Impact factor: 5.103

7.  Calcium phosphate nanoparticles induce mucosal immunity and protection against herpes simplex virus type 2.

Authors:  Qing He; Alaina Mitchell; Tulin Morcol; Steve J D Bell
Journal:  Clin Diagn Lab Immunol       Date:  2002-09

Review 8.  Update on emerging antivirals for the management of herpes simplex virus infections: a patenting perspective.

Authors:  Aswani D Vadlapudi; Ramya K Vadlapatla; Ashim K Mitra
Journal:  Recent Pat Antiinfect Drug Discov       Date:  2013-04

9.  Use of baculovirus-expressed glycoprotein H in an enzyme-linked immunosorbent assay developed to assess exposure to chelonid fibropapillomatosis-associated herpesvirus and its relationship to the prevalence of fibropapillomatosis in sea turtles.

Authors:  Lawrence H Herbst; Shefali Lemaire; Ada R Ene; David J Heslin; Llewellyn M Ehrhart; Dean A Bagley; Paul A Klein; Jack Lenz
Journal:  Clin Vaccine Immunol       Date:  2008-03-26

10.  Modified FGF4 signal peptide inhibits entry of herpes simplex virus type 1.

Authors:  H Bultmann; J S Busse; C R Brandt
Journal:  J Virol       Date:  2001-03       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.